The board of directors at KaliVir Immunotherapeutics has a history of experience in the medical and research fields, as well as in business administration and marketing. Members of the board have worked as oncologists, fellows, and professors at renowned institutions such as Memorial Sloan Kettering Cancer Center, Johns Hopkins School of Medicine, and University of Pittsburgh School of Medicine. In addition, some members have also held positions such as Vice President at Parker Institute for Cancer Immunotherapy and Chair of the Food and Drug Administration Cellular, Tissues, and Gene Therapies Advisory Committee.
Dmitriy Zamarin
Clinical Advisor
Greg Delgoffe
Scientific Advisor
Jon Wigginton
Director
Jonathan Rosenberg
Clinical Advisor
Jorge Nieva
Clinical Advisor
Kurt Rote
Director
Lisa Butterfield
Scientific Advisor
Mitesh Borad
Clinical Advisor
Richard Jones
Director
Terry Hermiston
Director
Tom Leonard
Director
Tullia Bruno
Scientific Advisor
View all